MedTrace Logo

Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection Patients Using Infrared Spectroscopy

NCT06309628 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-05-31

No results posted yet for this study

Summary

This study will sample and analyze volatile organic compounds (VOCs) from participants considered to be at risk for developing rejection following lung transplant by using infrared spectroscopy.

Conditions

  • Lung Transplant Rejection

Interventions

DIAGNOSTIC_TEST

Breathe sample

Patients will provide two breathe sample into the Breathe device to see if their VOC patterns can be used to diagnose lung transplant rejection.

Sponsors & Collaborators

  • Breathe BioMedical Inc

    collaborator INDUSTRY

  • Paragonix Technologies

    lead INDUSTRY

Principal Investigators

  • Matthew Hartwig, MD · Duke University

  • Matthew Pipeling · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-21
Primary Completion
2025-05-09
Completion
2025-05-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06309628 on ClinicalTrials.gov